Eunice had a fever, her legs were painful, sometimes swollen. This prompted her to see a doctor and after some tests, she was told she had multidrug-resistant tuberculosis (MDR-TB). She is now on a 18-month treatment, taking 13 pills per day. On the occasion of World TB Day, Eunice and her doctor talk to us on the realities of MDR-TB treatment in Kenya.

➡️ For more stories, visit our online channel: [ Ссылка ]

Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]

Contact: press@medicinespatentpool.org

About the Medicines Patent Pool:
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries.

Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.

To date, MPP has signed agreements with ten patent holders for thirteen HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals and a tuberculosis treatment. MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC).

свернуть